Occumox Drop

Occumox Drop

Therapeutic Class:
Get Quote

NEYPAC EYE DROPS belongs to a group of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs), mainly suggested to relieve eye irritation, pain, and redness after a cataract eye surgery. This medicine is also indicated to reduce the risk of macular oedema, swelling in the back of the eye after cataract surgery in patients dealing with diabetes. Patients often experience redness, itchiness, inflammation, in their eyes for a week, and these symptoms will disappear after a few weeks. Macular oedema is an eye condition that can even cause permanent loss of vision and occurs when blood vessels present in the retina’s light-sensitive part, the eye gets leaked.

NEYPAC EYE DROPS consists of Nepafenac, which blocks the action of prostaglandin H synthase (cyclooxygenase), which is an enzyme required for prostaglandin. These prostaglandins are responsible for causing pain, redness, inflammation in the eyes, so blocking prostaglandins it provides relief in painful eye conditions.

Salt Composition: Nepafenac
Strength: (0.1% w/v)
Pack Size: 5 ML
Uses: Treatment of Post-operative eye pain and inflammation
Table Header
Salt Composition
(0.1% w/v)
Pack Size
5 ML
Treatment of Post-operative eye pain and inflammation
SKU d9e42bf8aa22 Category
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Occumox Drop which is also known as Nepafenac and Manufactured by Intas Optima. It is available in strength of Occumox Drop is supplied for Pharmacies / Drug Stores / Hospitals / Ship Chandlers Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed